EBS obtains rights to Hikma's Kloxxado naloxone spray
Emergent BioSolutions (NYSE:EBS) has entered into an agreement for the exclusive commercial rights in the U.S. and Canada for Hikma's opioid overdose product Kloxxado. Kloxxado is a 8mg naloxone nasal spray product used for the emergency treatment of known or suspected opioid overdoses.
Hikma Pharma Inks Exclusive Commercial Deal With Emergent BioSolutions For KLOXXADO Nasal Spray 8 Mg
Hikma Pharmaceuticals plc (HIK, HIK.L) announced Tuesday that it has entered an exclusive commercial partnership with Emergent
Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the sale of KLOXXADO® naloxone HCl nasal spray 8 mg in the U.
Emergent BioSolutions, Hikma enter partnership for sale of Kloxxado nasal spray
Hikma Pharmaceuticals (HKMPF) announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (EBS) for the sale of
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to
Doctor Shares Best 'Hacks' To Get Rid of a Stubborn Cough
Chowdhury's first suggestion was to make some water warm, add salt and gargle it in the back of your throat. "This helps ...
New York Post23d
Which products will actually unstuff your nose — as FDA moves to ban decongestant that doesn’t really work
US officials are moving to phase out phenylephrine, a decongestant found in products like Sudafed, concluding that it doesn't actually relieve nasal congestion. NY Post composite Changes are ...
Las Vegas Sun3d
Alternative remedies prescribed as FDA weighs whether to pull plug on drug
Dr. Scott Manthei of the Nevada Ear and Sinus Institute has been advising patients against taking drugs like Sudafed for ...
JD Supra2d
The Commercial Potential – and Practical Challenges – of Marketing OTC Drugs With ‘Additional Conditions for Nonprescription Use’
The Food and Drug Administration’s (FDA or Agency) final rule on Additional Conditions for Nonprescription Use (ACNU) paves the way for some ...
The Associated Press - Business News on MSN23d
FDA says decongestant in many cold medicines doesn't work. So what does?
Purchasers need to provide a photo ID. Beyond those products, most of the other options are over-the-counter nasal sprays or solutions. Saline drops and rinses are a quick way to clear mucus ...
Kennebec Journal4dOpinion
Hilary Koch: The FDA’s Pinocchio problem
An experience with over-the-counter nasal spray showed Hilary Koch how drug manufacturers often rely on sins of omission.